Ryan Savitz Magenta Therapeutics, Inc. (MGTA) insider trading activity

MGTA Quotes by TradingView

Ryan Savitz is CFO & CBO of Magenta Therapeutics, Inc.. Currently has a direct ownership of 0 shares of MGTA, which is worth approximately $0. The most recent transaction as insider was on Dec 04, 2025, when has been sold 20,000 shares (Common Stock) at a price of $45.18 per share, resulting in proceeds of $903,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

Ryan Savitz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 04 2025
SELL
Open market or private sale
$903,600 $45.18 p/Share
20,000 Reduced 100.0%
0 Common Stock
Dec 04 2025
BUY
Exercise of conversion of derivative security
$168,800 $8.44 p/Share
20,000 Added 50.0%
20,000 Common Stock
Sep 09 2025
SELL
Open market or private sale
$700,000 $35.0 p/Share
20,000 Reduced 100.0%
0 Common Stock
Sep 09 2025
BUY
Exercise of conversion of derivative security
$168,800 $8.44 p/Share
20,000 Added 50.0%
20,000 Common Stock
RS

Ryan Savitz

CFO & CBO
New York, NY

Track Institutional and Insider Activities on MGTA

Follow Magenta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MGTA shares.

Notify only if

Insider Trading

Get notified when an Magenta Therapeutics, Inc. insider buys or sells MGTA shares.

Notify only if

News

Receive news related to Magenta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MGTA